Related Experiment Video
Updated: May 1, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Pneumococcal vaccination in Europe: schedule adherence
Alain Gervaix1, Filippo Ansaldi2, António Brito-Avô3
1Paediatric Emergency Medicine Service, University Children's Hospital, Geneva, Switzerland.
Adherence to pneumococcal conjugate vaccine (PCV) schedules is lower than for DTaP vaccines, especially for booster doses. Higher adherence is seen in countries recommending and funding PCV, highlighting the need for tailored national strategies to improve timely vaccination.
Area of Science:
- Public Health
- Vaccinology
- Pediatrics
Background:
- Nonadherence to pneumococcal conjugate vaccine (PCV) schedules can compromise protection against pneumococcal disease.
- Understanding adherence patterns is crucial for public health strategies.
- Variations in adherence exist across different countries and vaccine schedules.
Purpose of the Study:
- To assess adherence to recommended PCV dosing schedules in European countries.
- To compare PCV adherence with other routine childhood vaccinations like diphtheria-tetanus-acellular pertussis (DTaP).
- To identify factors associated with higher PCV schedule adherence.
Main Methods:
- Comparative analysis of PCV schedule adherence across European nations.
- Assessment of primary series and booster dose completion rates.
- Correlation of adherence rates with national vaccination policies (recommendation and funding status).
Main Results:
- Adherence to PCV schedules was found to be lower compared to DTaP schedules.
- Higher adherence rates were observed in countries where PCV vaccination is officially recommended and publicly funded.
- Booster dose adherence was frequently lower than primary series completion, with delays in administration beyond recommended ages.
Conclusions:
- Timely childhood vaccination with PCV, according to national schedules, requires targeted interventions.
- Improving PCV adherence necessitates country-specific strategies addressing national, regional, and local levels.
- Engaging diverse stakeholders is essential for enhancing vaccine schedule compliance.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
09:20Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Vaccinations
Pneumonia III: Complications and Assessment
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction